Valuation: PolyNovo Limited

Market Cap 656M 459M 402M 374M 343M 647M 44.31B 4.45B 1.74B 21.68B 1.72B 1.69B 74.9B P/E 2026 *
87.7x
P/E 2027 * 33.7x
Enterprise Value 631M 441M 387M 359M 330M 622M 42.59B 4.28B 1.67B 20.84B 1.66B 1.62B 71.98B EV / Sales 2026 *
4.16x
EV / Sales 2027 * 3.39x
Free-Float
88.97%
Yield 2026 *
-
Yield 2027 * -
1 day-5.26%
1 week-12.62%
Current month-2.17%
1 month-5.26%
3 months-11.76%
6 months-17.43%
Current year-26.83%
1 week 0.89
Extreme 0.89
1.03
1 month 0.89
Extreme 0.89
1.04
Current year 0.86
Extreme 0.865
1.3
1 year 0.86
Extreme 0.865
1.66
3 years 0.86
Extreme 0.865
2.78
5 years 0.84
Extreme 0.835
2.78
10 years 0.17
Extreme 0.17
4.08
Manager TitleAgeSince
Chief Executive Officer - 2025-11-30
Director of Finance/CFO - 2018-12-11
Chief Tech/Sci/R&D Officer - 2026-05-31
Director TitleAgeSince
Chairman - 2025-10-26
Director/Board Member 65 2019-10-27
Director/Board Member - 2020-05-12
Date Insider Type Main position Quantity % Market Cap.
3/16/26 Buy

Director

151,000 0.0219%
2/27/26 Buy

Chairman

30,000 0.0043%
2/27/26 Buy

Director

100,000 0.0145%
Change 5-day change 1-year change 3-year change Capi.($)
-5.00%-12.62%-29.96%-43.04% 460M
+0.90%+12.66%-20.01%-12.00% 174B
-0.56%+1.76%-10.65%-7.95% 105B
-0.82%+1.35%+2.60%+56.07% 58.97B
-0.94%-1.00%+33.41%+56.27% 52.24B
-0.44%-1.11%-15.51%-42.17% 42.39B
-4.89%-5.73% - - 33.05B
-4.44%-1.79%-16.08%-45.31% 28.84B
-0.23%-0.16%+63.73%-5.01% 25.38B
-0.56%-0.42%-5.87%-9.27% 20.64B
Average -1.52%-0.17%+0.18%-5.82% 54.1B
Weighted average by Cap. -0.21%+3.85%-4.60%-0.21%

Financials

2026 *2027 *
Net sales 152M 106M 92.92M 86.26M 79.27M 149M 10.23B 1.03B 402M 5.01B 398M 390M 17.3B 181M 127M 111M 103M 94.89M 179M 12.25B 1.23B 482M 5.99B 477M 466M 20.71B
Net income 7.01M 4.91M 4.3M 3.99M 3.67M 6.91M 474M 47.55M 18.61M 232M 18.42M 18.02M 800M 19.31M 13.51M 11.84M 10.99M 10.1M 19.03M 1.3B 131M 51.24M 638M 50.72M 49.63M 2.2B
Net Debt -25.56M -17.89M -15.67M -14.55M -13.37M -25.19M -1.73B -173M -67.84M -844M -67.14M -65.69M -2.92B -41.66M -29.15M -25.54M -23.71M -21.79M -41.05M -2.81B -282M -111M -1.38B -109M -107M -4.75B
Logo PolyNovo Limited
PolyNovo Limited is an Australia-based medical technology company. The Company’s business includes designing, manufacturing and selling biomedical devices. Its principal activity is the development of medical devices for medical applications, utilizing the patented bioabsorbable polymer technology NovoSorb. NovoSorb is a family of proprietary medical grade polymers that can be utilized to manufacture medical devices designed to support tissue repair. NovoSorb polymer devices can be expressed in a variety of physical formats including foam, coatings, fibers, plastic structures, films, and biologic carriers. Its products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb MTX. NovoSorb BTM is a bilayer dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma or burn. NovoSorb MTX has applicability for single stage grafting in burns, chronic, and surgical wounds.
Employees
301
Date Price Change Volume
26-07-22 A$0.9025 -5.00% 3,899,312
26-07-22 A$0.9500 0.00% 829,666
26-07-21 A$0.9500 -2.06% 1,115,704
26-07-20 A$0.9700 -1.02% 1,230,568
26-07-17 A$0.9800 -4.85% 1,069,640
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
0.9500AUD
Average target price
1.705AUD
Spread / Average Target
+79.46%

Quarterly revenue - Rate of surprise